Release Date: 31/07/18 08:22 Summary: JUNE QUARTER ACTIVITIES REPORT Price Sensitive: Yes Download Document 647.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%